CD4 and inflammatory bowel disease: Relying on competing with Wnt ligands for LRP5/6 receptors [53, 54], DKK1 has a role in promoting the development and differentiation of immunocytes [55], such as macrophages, DCs, and CD4+ T cells, which actively participates in the progression of inflammatory bowel disease [56–58].